Bio Protocol vs Harmony — how do they compare? Bio Protocol trades at Rp439.42 (market cap Rp994,94M, Rp174,97M 24h volume), while Harmony trades at Rp14.29 (market cap Rp209,23M, Rp278,98M 24h volume). The key difference: Bio Protocol is far larger — about 4.8× Harmony's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Harmony's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Harmony for 152 Days on average.
| BIO | ONE | |
|---|---|---|
Market Cap | Rp994,94M | Rp209,23M |
Volume (24h) | Rp174,97M | Rp278,98M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 15B ONE |
Typical Hold Time | 18 Days | 152 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Harmony (ONE) is currently trading at Rp15.004 with a market cap of Rp219.45M, showing bearish technical signals across multiple indicators. The asset faces selling pressure with moving averages indicating sustained downward momentum while oscillators remain neutral. Current price sits below key support levels at S1 (Rp21) and pivot point (Rp21), suggesting continued weakness in the short term.
Overall outlook remains cautious with technical indicators favoring sellers. Key opportunities include potential rebounds from oversold conditions, while major risks include continued bearish momentum and low trading volume. Investors should monitor for protocol updates and exchange liquidity improvements that could catalyze price recovery.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Harmony is a blockchain platform designed to facilitate the creation and use of decentralized applications. Focusing on processing speed and validation, the Harmony mainnet aims to revolutionize block creation.
Read more on ONE →